BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19737550)

  • 1. Development of ELISA for the specific determination of autoantibodies against envoplakin and periplakin in paraneoplastic pemphigus.
    Probst C; Schlumberger W; Stöcker W; Recke A; Schmidt E; Hashimoto T; Zhu XJ; Zillikens D; Komorowski L
    Clin Chim Acta; 2009 Dec; 410(1-2):13-8. PubMed ID: 19737550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and characterization of anti-envoplakin linker autoantibodies in paraneoplastic pemphigus using specific bead-based assay.
    Mouquet H; Drenovska K; Lartigue A; Joly P; Drouot L; Thomas M; Tron F; Gilbert D
    Clin Immunol; 2008 Nov; 129(2):304-12. PubMed ID: 18790674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of anti-envoplakin and anti-periplakin autoantibodies by ELISA in patients with paraneoplastic pemphigus.
    Huang Y; Li J; Zhu X
    Arch Dermatol Res; 2009 Oct; 301(10):703-9. PubMed ID: 18820940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of autoantibodies against the linker subdomains of envoplakin and periplakin in the pathogenesis of paraneoplastic pemphigus.
    Li J; Bu DF; Huang YC; Zhu XJ
    Chin Med J (Engl); 2009 Mar; 122(5):486-95. PubMed ID: 19323896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of autoantibodies to periplakin and envoplakin in paraneoplastic pemphigus but not idiopathic pulmonary fibrosis using full-length recombinant proteins.
    Muro Y; Sugiura K; Shiraki A; Ishii N; Hashimoto T; Akiyama M
    Clin Chim Acta; 2014 Feb; 429():14-7. PubMed ID: 24275244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extremities of the N-terminus of envoplakin and C-terminus of its linker subdomain are major epitopes of paraneoplastic pemphigus.
    Wang X; Chen T; Zhao J; Peng Y; Chen X; Tu P; Zhu X; Liu Z; Wang M
    J Dermatol Sci; 2016 Oct; 84(1):24-29. PubMed ID: 27427435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitopes in the linker subdomain region of envoplakin recognized by autoantibodies in paraneoplastic pemphigus patients.
    Zhang B; Zheng R; Wang J; Bu D; Zhu X
    J Invest Dermatol; 2006 Apr; 126(4):832-40. PubMed ID: 16470171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraneoplastic pemphigus sera react strongly with multiple epitopes on the various regions of envoplakin and periplakin, except for the c-terminal homologous domain of periplakin.
    Nagata Y; Karashima T; Watt FM; Salmhofer W; Kanzaki T; Hashimoto T
    J Invest Dermatol; 2001 Apr; 116(4):556-63. PubMed ID: 11286623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a Newly Available ELISA for Envoplakin Autoantibodies for the Diagnosis of Paraneoplastic Pemphigus.
    Powell JG; Grover RK; Plunkett RW; Seiffert-Sinha K; Sinha AA
    J Drugs Dermatol; 2015 Oct; 14(10):1103-6. PubMed ID: 26461820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The members of the plakin family of proteins recognized by paraneoplastic pemphigus antibodies include periplakin.
    Mahoney MG; Aho S; Uitto J; Stanley JR
    J Invest Dermatol; 1998 Aug; 111(2):308-13. PubMed ID: 9699735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory diagnosis of paraneoplastic pemphigus.
    Poot AM; Diercks GF; Kramer D; Schepens I; Klunder G; Hashimoto T; Borradori L; Jonkman MF; Pas HH
    Br J Dermatol; 2013 Nov; 169(5):1016-24. PubMed ID: 23796242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibody production from a thymoma and a follicular dendritic cell sarcoma associated with paraneoplastic pemphigus.
    Wang J; Bu DF; Li T; Zheng R; Zhang BX; Chen XX; Zhu XJ
    Br J Dermatol; 2005 Sep; 153(3):558-64. PubMed ID: 16120143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice.
    Amagai M; Nishikawa T; Nousari HC; Anhalt GJ; Hashimoto T
    J Clin Invest; 1998 Aug; 102(4):775-82. PubMed ID: 9710446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin A antibodies against desmoglein 1, envoplakin, periplakin and BP230 in a patient with atypical bullous pemphigoid.
    Yamaki F; Mayuzumi N; Ikeda S; Hashimoto T
    J Dermatol; 2010 Mar; 37(3):255-8. PubMed ID: 20507390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Author's reply to "detection of anti-periplakin autoantibodies during idiopathic pulmonary fibrosis" by Taillé et al.
    Muro Y; Tsuchisaka A; Ishii N; Hashimoto T; Sugiura K; Akiyama M
    Clin Chim Acta; 2014 Jun; 433():194. PubMed ID: 24685575
    [No Abstract]   [Full Text] [Related]  

  • 16. Paraneoplastic pemphigus in children and adolescents.
    Mimouni D; Anhalt GJ; Lazarova Z; Aho S; Kazerounian S; Kouba DJ; Mascaro JM; Nousari HC
    Br J Dermatol; 2002 Oct; 147(4):725-32. PubMed ID: 12366419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sera from patients with toxic epidermal necrolysis contain autoantibodies to periplakin.
    Park GT; Quan G; Lee JB
    Br J Dermatol; 2006 Aug; 155(2):337-43. PubMed ID: 16882172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of five serological assays for the diagnosis of paraneoplastic pemphigus.
    Kelly S; Culican S; Silvestrini RA; Vu J; Schifter M; Fulcher DA; Lin MW
    Pathology; 2015 Jan; 47(1):58-61. PubMed ID: 25474518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Envoplakin and periplakin are the paraneoplastic pemphigus antigens.
    Kiyokawa C
    Kurume Med J; 1999; 46(1):71-8. PubMed ID: 10319615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of autoantibodies against alpha-2-macroglobulin-like 1 in paraneoplastic pemphigus sera utilizing novel green fluorescent protein-based immunoassays.
    Bazzini C; Begré N; Favre B; Hashimoto T; Hertl M; Schlapbach C; Borradori L
    J Dermatol Sci; 2020 Jun; 98(3):173-178. PubMed ID: 32439251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.